CAT
Caterpillar Inc.
CAT has the edge over EBF overall, supported by stronger modeled upside and stronger fundamentals.
EBF
Ennis, Inc.
EBF offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
EBF Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
EBF's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
EBF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $18.11 | -15% |
| Fair | 13x | $20.33 | -4.3% |
| Current | 14x | $21.24 | — |
| Expensive | 17x | $26.47 | +25% |
Historical ranges are pointers, not guarantees.
EBF has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
EBF Forward outlook
There aren't enough analyst estimates for EBF to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
EBF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.53 | -5.6% |
| Q2 2026 | $1.67 | +11% |
| Q1 2026 | $1.66 | +7.8% |
| Q4 2025 | $1.65 | +3.8% |
| Q3 2025 | $1.62 | +2.5% |
| Q2 2025 | $1.51 | -5.6% |
| Q1 2025 | $1.54 | -6.1% |
| Q4 2024 | $1.59 | -7% |
EBF has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over EBF on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over EBF on profitability, with a higher operating margin.
EBF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $102M | +3.4% |
| Q2 2026 | $98.6M | +1.5% |
| Q1 2026 | $96.4M | +4% |
| Q4 2025 | $100.2M | +0.4% |
| Q3 2025 | $98.7M | -0.4% |
| Q2 2025 | $97.2M | -5.7% |
| Q1 2025 | $92.7M | -4.9% |
| Q4 2024 | $99.8M | -4.6% |
EBF's revenue has held roughly level: $102M last quarter, up 3.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +0.8 points |
| Q2 2026 | 14% | +0.1 points |
| Q1 2026 | 13% | -0.5 points |
| Q4 2025 | 15% | +1.9 points |
| Q3 2025 | 13% | -0.8 points |
| Q2 2025 | 14% | +0.3 points |
| Q1 2025 | 13% | -0.3 points |
| Q4 2024 | 13% | +0.5 points |
EBF's operating margin was 13% last quarter, up 0.8 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over EBF on cash flow, with more consistent year-over-year improvement.
EBF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.3M | +25% |
| Q2 2026 | $20.9M | +217% |
| Q1 2026 | $9.7M | -13% |
| Q4 2025 | $15.7M | -10% |
| Q3 2025 | $9M | -16% |
| Q2 2025 | $6.6M | -68% |
| Q1 2025 | $11.1M | -26% |
| Q4 2024 | $17.5M | +6.8% |
EBF's free cash flow has been positive every quarter for seven years: $58M over the past year, up 30% from the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over EBF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
EBF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -194K shares |
| 1 year | -1.8% | -464K shares |
| 3 years | -2.8% | -723K shares |
| 5 years | -3.2% | -843K shares |
| Available history | -2.6% | -683K shares |
EBF has 25M diluted shares, down 1.8% from a year ago, with $6M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $5.9M |
| Q3 2025 | $3.5M |
| Q2 2025 | $5M |
| Q1 2025 | $9,000 |
| Q4 2024 | — |
EBF spent $6M buying back its own shares over the past year, down 31% from the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
EBF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.5x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
EBF has the edge over CAT on leverage, with a lower net debt burden relative to earnings.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
EBF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.6 | Neutral |
| Stochastic | 19.3 | Oversold |
EBF's weekly RSI is 49 (neutral) and its Stochastic is 19 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
EBF PE vs Industrials Sector
| Metric | EBF | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 24x | 42% below |
| PE % | 57 | 58 | 1 pt below |
EBF has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
EBF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.9 | 3.1% below |
| 20 week MA | $21.7 | 2.1% below |
| 50 week MA | $20.8 | 2.1% above |
| 100 week MA | $19.8 | 7.1% above |
| 200 week MA | $20.5 | 3.5% above |
EBF has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
EBF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.9 | $16.8 | -23% |
| 2021 | $16.8 | $19.3 | +15% |
| 2022 | $19.3 | $22.5 | +16% |
| 2023 | $22.5 | $21.9 | -2.6% |
| 2024 | $21.9 | $21.1 | -3.9% |
| 2025 | $21.1 | $18.3 | -13% |
| 2026 YTD | $18.3 | $21.2 | +16% |
EBF has the edge over CAT on returns for 2026, with the stronger performance.